SCHEMBL10690604

SCHEMBL10690604

CCC1(c2ccccc2OC)Cc2ccccc2N(C)C1=O

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 2/20 0.42
L3MBTL1 Q9Y468 2/20 0.42
ATM Q13315 1/20 0.42
ADRA1A P35348 4/20 0.41
ADRA1D P25100 3/20 0.41
ADRA1B P35368 3/20 0.41
ALDH1A1 P00352 2/20 0.40
HTR7 P34969 2/20 0.40
SCN9A Q15858 1/20 0.39
CYP1A2 P05177 1/20 0.38
CYP3A4 P08684 1/20 0.38
TSHR P16473 1/20 0.38
ADRA2B P18089 1/20 0.38
MAPT P10636 2/20 0.38
KDM4E B2RXH2 1/20 0.38
HCRTR1 O43613 1/20 0.38
LMNA P02545 1/20 0.38
HPGD P15428 1/20 0.38
DRD2 P14416 1/20 0.38
DRD3 P35462 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10695992 0.87 SCN9A (0.39) TDP1L3MBTL1ATMADRA1AADRA1D
SCHEMBL10691444 0.86 ALDH1A1 (0.43) TDP1L3MBTL1ATMADRA1AADRA1D
SCHEMBL10694109 0.83 POLB (0.35) L3MBTL1ADRA1AADRA1DADRA1BALDH1A1
SCHEMBL10694392 0.82 NPC1 (0.47) ALDH1A1HTR7TSHRMAPTKDM4E
SCHEMBL10689170 0.81 ADRA1A (0.40) ADRA1AADRA1DADRA1BALDH1A1SCN9A
SCHEMBL10759620 0.78 DRD2 (0.41) TDP1ADRA1AADRA1DADRA1BALDH1A1
SCHEMBL10754672 0.78 SMPD1 (0.51) CYP1A2CYP3A4MAPTDRD2DRD3
SCHEMBL10691597 0.78 ADRA1A (0.39) TDP1L3MBTL1ATMADRA1AADRA1D
Oxalic Acid SCHEMBL10694123 0.75 SMPD1 (0.48) ALDH1A1CYP3A4MAPTKDM4E
SCHEMBL10694474 0.73 CYP3A4 (0.41) TDP1L3MBTL1ADRA1AADRA1DADRA1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4778793-A CONTROLLING CALCIUM CONCENTRATION-CARDIOVASCULAR DISORDERS HOECHST AKTIENGESELLSCHAFT (DE) 1988-10-18 US disclosed
EP-0212216-A1 Dihydroquinolinone derivatives, processes for their preparation, medicaments containing them, the use of these medicaments, and intermediates for their preparation HOECHST AKTIENGESELLSCHAFT (DE) 1987-03-04 EP disclosed